Prism Medico Pharmacy Ltd vs Royal Sense Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 34.99 as of 26 Oct 15:30 . The P/E Ratio of Prism Medico & Pharmacy Ltd is 0 as of March 2024 .The P/E Ratio of Royal Sense Ltd is 34 as of March 2024 . The Market Cap of Prism Medico & Pharmacy Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Royal Sense Ltd is ₹ 53.9 crore as of March 2024 . The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.28 crore. This represent the decline of -67.86% The revenue of Royal Sense Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the decline of -50% The ebitda of Royal Sense Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ -0.09 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -16.49% The net profit of Royal Sense Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on September 2023 . This represents a CAGR of 0.0% over 8 yearsThe Dividend Payout of Royal Sense Ltd changed from 0 % on March 2021 to 0 % on September 2023 . This represents a CAGR of 0.0% over 8 years .

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

About Royal Sense Ltd

Royal Sense Limited was incorporated as a Public Limited Company pursuant to a Certificate of Incorporation dated April 06, 2023, issued by the Registrar of Companies, Central Registration Centre.
Prior to the incorporation of Company, the Promoter Rishabh Arora was running the business in sole proprietorships under the name 'M/s Royal Traders, M/s PHT & M/s Anaya'. In 2015, the Company started their business under proprietorship as M/s Royal Traders; in 2018 as M/s PHT and proprietorship as M/s Anaya in 2020.
Later on, April 28, 2023, the running business of the aforesaid proprietorship concern was acquired by the Company, along with the assets and liabilities of the proprietorship concern as going concern.
The Company has absorbed the business line & distribution network of firms. 'RoyalSense' is the suppliers of high quality goods that meet international standards required for hospitals, laboratories, institutions and clinics to provide health services.

FAQs for the comparison of Prism Medico & Pharmacy Ltd and Royal Sense Ltd

Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or Royal Sense Ltd?

Market cap of Prism Medico & Pharmacy Ltd is 47 Cr while Market cap of Royal Sense Ltd is 36 Cr

What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and Royal Sense Ltd?

The stock performance of Prism Medico & Pharmacy Ltd and Royal Sense Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prism Medico & Pharmacy Ltd and Royal Sense Ltd?

As of October 26, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹34.99. On the other hand, Royal Sense Ltd stock price is INR ₹68.4.

How do dividend payouts of Prism Medico & Pharmacy Ltd and Royal Sense Ltd compare?

To compare the dividend payouts of Prism Medico & Pharmacy Ltd and Royal Sense Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.